12 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Disease Progression ... characteristic features Clinical ... Diagnosis: Latent ... #TB #Diagnosis ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Disease Progression ... characteristic features Clinical ... Diagnosis: Latent ... #TB #Diagnosis ... #Management #Treatment
Tuberculosis Testing

LATENT TB
• LTBI is diagnosed when an asymptomatic patient has a positive TST or IGRA
TB • LTBI is diagnosed ... result with no clinical ... • The goal of diagnosing ... intermediate risk of disease ... used to exclude pulmonary
Pott's Disease in Tuberculosis - Diagnosis and Management Summary
Epidemiology:
 - Typically from TB endemic areas
 -
Pott's Disease in ... Diagnosis and Management ... extrapulmonary cases Clinical ... signs/symptoms of active ... TB #Diagnosis #Management
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... Lung Abscess - Clinical ... Lung Abscess Management ... residual lesion or is clear ... Lung #Abscess #pulmonary
Stiff Person Syndrome (SPS) - Diagnosis and Management Summary

Epidemiology:
 • Prevalence: 1-2 cases per million -
and Management ... Clinical Manifestations ... Baclofen • Severe Disease ... #Management #treatment ... #neurology
Amyotrophic Lateral Sclerosis (ALS) Summary
ALS: combination of the clinical examination finding of amyotrophy with the pathologic
Excessive glutamate activity ... Presentation: - Disease ... course of the disease ... Lateral #Sclerosis #neurology ... #diagnosis #management
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
salivary ducts Clinical ... : • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... muscarinic agonists • Active ... #Management
Anti-GIomeruIar Basement Membrane Disease (Goodpasture's Disease)

What is it? A small vessel vasculitis with circulating antibodies directed
hemorrhage Diagnosis ... Daily sessions to clear ... active antibodies ... Goodpastures #AntiGBM #diagnosis ... #nephrology #pulmonary
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
worsening of that disease ... noncompliance • Clinical ... initiation Clinical ... • Persistently active ... #Management